Molecular imaging of tumor-associated angiogenesis using a novel magnetic resonance imaging contrast agent targeting αvβ 3 integrin.
about
Advance of molecular imaging technology and targeted imaging agent in imaging and therapyBiomarkers in preclinical cancer imaging.Noninvasive monitoring of early antiangiogenic therapy response in human nasopharyngeal carcinoma xenograft model using MRI with RGD-conjugated ultrasmall superparamagnetic iron oxide nanoparticles.Nodular Thyroid Disease and Thyroid Cancer in the Era of Precision Medicine.
P2860
Molecular imaging of tumor-associated angiogenesis using a novel magnetic resonance imaging contrast agent targeting αvβ 3 integrin.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
Molecular imaging of tumor-ass ...... gent targeting αvβ 3 integrin.
@en
Molecular imaging of tumor-ass ...... gent targeting αvβ 3 integrin.
@nl
type
label
Molecular imaging of tumor-ass ...... gent targeting αvβ 3 integrin.
@en
Molecular imaging of tumor-ass ...... gent targeting αvβ 3 integrin.
@nl
prefLabel
Molecular imaging of tumor-ass ...... gent targeting αvβ 3 integrin.
@en
Molecular imaging of tumor-ass ...... gent targeting αvβ 3 integrin.
@nl
P2093
P2860
P1476
Molecular imaging of tumor-ass ...... gent targeting αvβ 3 integrin.
@en
P2093
Dieter De Naeyer
Isabelle Debergh
Nancy Van Damme
Peter Smeets
Philippe Robert
Piet Pattyn
Pieter Demetter
Sabin Carme
P2860
P2888
P304
P356
10.1245/S10434-013-3444-1
P50
P577
2013-12-20T00:00:00Z
P5875
P6179
1026915532